Urovant Sciences Ltd. (UROV) News

Urovant Sciences Ltd. (UROV): $16.24

0.01 (+0.06%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter UROV News Items

UROV News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest UROV News From Around the Web

Below are the latest news stories about Urovant Sciences Ltd that investors may wish to consider to help them evaluate UROV as an investment opportunity.

NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Urovant Sciences Ltd. (Nasdaq - UROV), Cubic Corporation (NYSE - CUB), CoreLogic, Inc. (NYSE - CLGX)

BALA CYNWYD, PA / ACCESSWIRE / February 13, 2021 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law .Brodsky & Smith, LLCBALA CYNWYD, PA / ACCESSWIRE / February 13, 2021 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions.

Yahoo | February 13, 2021

Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results

Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results

Yahoo | February 12, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, NHLD, COHR, UROV; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: MDC Partners Inc. (NASDAQ: MDCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Stagwell Media LP. Stagwell and its affiliates are expected to hold approximately 79% of the common equity of the combined company after closing. If you are an MDC shareholder, click here to learn more about your rights and options. National Holdings Corporation (NASDAQ: NHLD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to B. Riley Financial, Inc. for $3.25 per share. If you are a National Holdings shareholder,...

Yahoo | February 4, 2021

Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS

Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

Yahoo | January 31, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds JWS, BRPA, and UROV Shareholders About Its Ongoing Investigations

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Yahoo | January 29, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, CBMG, WTRE, NAV, UROV; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | January 20, 2021

Lifshitz Law Firm, P.C. Announces Investigation of CBMG, HMSY, UROV, and WDR

NEW YORK, NY / ACCESSWIRE / January 18, 2021 / Lifshitz Law Firm, P.:Cellular Biomedicine Group, Inc.

Yahoo | January 18, 2021

ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV

NEW YORK, Jan. 16, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to a consortium that includes members of Cellular Biomedicine management and several entities. If you are a Cellular Biomedicine shareholder, click here to learn more about your rights and options. Cancer Genetics, Inc. (NASDAQ: CGIX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with StemoniX, Inc. Under the merger agreement, Cancer Genetics will acquire all of the outstanding capital stock of StemoniX...

Yahoo | January 16, 2021

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:

Yahoo | January 16, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FFG, NHLD, HCAP, NAV, UROV; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

Yahoo | January 12, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4746 seconds.